← AlphaSignal

DXCM

★★★☆☆ Watchopenrouter

DexCom, Inc.

Healthcare

세션 움직임

$89.60

+$0.84+0.95%

거래량 0.59× 평균

76/100 quant · tgt $94.12

RS60 +21.0% vs SPY · ADV$ 447.8M

푸시 2026-08-19T09:35 · 프리마켓 · 푸시 스냅샷

직전 스캔 대비

2026-08-18 → 2026-08-19

점수-0.9가격+$0.84 · +0.95%공시-15.0

참고용이며 매수/매도 신호가 아닙니다. 스캔 이력과 캐시된 뉴스·공시로 구성됩니다.

스냅샷 시세

세션 2026-08-18 · 스캔 2026-08-19 · 푸시 2026-08-19T09:35 · 프리마켓

시세 상세 보기
종가/스캔가
$89.60
전일 종가
$88.76
푸시 최신가
$89.60 · 프리마켓
세션 시가
$89.49
직전 세션 범위
$88.98 – $91.50
52주 범위
$54.11 – $91.96
세션 거래량
3,199,079
평균 거래량 (20일)
5,391,149
시가총액
$33.81B
PER (TTM)
35.42
Forward PER
28.68
배당 수익률
0.00%
1년 목표가 추정
$94.12
다음 실적
2026-10-29

Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. 프리/애프터 시세는 유동성이 얇아 정규장과 다를 수 있습니다.

$1,000 넣었다면 지금

1년 전

$1,108

+11%

5년 전

$691

−31%

Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.

시장 브리핑

선별된 요약입니다 — 매매 신호가 아닙니다. 헤드라인·링크는 제공된 그대로 표시됩니다.

  • DexCom (DXCM) Rebounds On Growth Hopes, Does It Look Fully Valued?

    DexCom stock reacts to recent performance and fundamentals DexCom (DXCM) has attracted investor attention after a recent share price move, with the stock closing at US$89.75. The company’s returns over the past month and past 3 months now stand out against its longer term record. See our latest analysis for DexCom. Short term momentum in DexCom has been strong, with the 30 day share price return of 17.09% and the 90 day share price return of 34.06% contrasting with a more modest 1 year total...

    Yahoo · 2026-08-17

  • DexCom (DXCM) Stock Sees Modest Fair Value Lift After Q2 And Clinical Updates

    DexCom’s latest analyst work shows a modest lift in the modelled fair value, with the price target figure moving from US$91.64 to US$94.12. This adjustment sits alongside mixed analyst commentary that balances positive Q2 2026 execution, new clinical data and guidance updates, and ongoing questions about valuation and sector sentiment. As you read on, you will see how these moving parts shape the current story around DexCom and how to keep track of future shifts in the narrative. Stay updated...

    Yahoo · 2026-08-17

  • 1 Surging Stock Worth Your Attention and 2 We Question

    Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.

    Yahoo · 2026-08-17

레딧 언급

공식 Reddit API로 가져온 공개 글 제목입니다 — 비공식·지연될 수 있으며 매매 신호가 아닙니다. Reddit과 제휴하지 않습니다. 링크는 Reddit으로 이동합니다.

이 종목과 맞는 최근 레딧 제목이 없습니다.

Price Chart

Daily prices from cache

Loading price history…

AI Analysis

  • Bull Thesis — DexCom, Inc. is positioned for growth with a strong EPS growth rate of 16% YoY and robust revenue momentum, driven by increasing demand for continuous glucose monitoring technology.
  • Risks — Potential risks include high debt levels and insider selling, as indicated by recent form4 cluster sell activity, which may raise concerns about management confidence.
  • Target Upside — With a current price of $89.60 and a target mean price of $94.12, there is an upside potential of approximately 5%.

Score History

2026-07-3076.0 pts · 2026-08-19

15 days of scans. Daily batch adds the next weekday automatically while the API is running.

  • DatePriceChgScoreRating
  • 2026-08-19$89.60+0.8476.0Watch
  • 2026-08-18$88.76-0.9976.9Watch
  • 2026-08-17$89.75-1.7376.3Watch
  • 2026-08-14$91.48+0.1975.7Watch
  • 2026-08-13$91.29+1.7675.8Watch
  • 2026-08-12$89.53+1.8876.6Watch
  • 2026-08-11$87.65+2.9078.3Watch
  • 2026-08-10$84.75+1.7379.2Watch
  • 2026-08-07$83.02+0.3679.8Watch
  • 2026-08-06$82.66-4.2880.5Buy
  • 2026-08-05$86.94-0.3777.6Watch
  • 2026-08-03$87.31+3.8677.3Watch
  • 2026-08-01$83.45+0.7079.4Watch
  • 2026-07-31$82.75+8.2177.3Watch
  • 2026-07-30$74.54—82.1Buy

Quant Breakdown

Revenue Growth
5.2
EPS Growth
16.0
ROE
12.0
PER Relative
0.3
Debt / Equity
7.8
FCF Margin
8.0
Analyst Upside
1.7
Insider / Sector
5.0
Momentum 3M
12.0
Earn. Surprise
8.0

Short volume (FINRA)

Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.

as of 2026-08-18 · finra_cnms
Short / total
50.2%
vs 20d (z)
-0.61
Short vol
543,188
Status
ok

Squeeze pressure score

full

25/100

Short leg
7
Call leg
59
Activity
0.0
Call vol share
53.8%
PCR (vol)
0.86
Call OI share
75.1%
ATM IV
54.5%

FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.

공시 점수 (Disclosure)

캐시된 SEC 공시 기반 News / Insider / Earnings 규칙 다리 — 참고용이며, beat/miss나 매수 신호가 아닙니다.

공시 점수

-15

as of 2026-08-19 · mongo_cache_only
News
0
Insider
-15
Earnings
0

아래 신호는 캐시된 공시의 규칙 히트입니다 — Risk / Constructive / Attention. Attention은 상승 신호가 아닙니다. 링크된 칩은 SEC 원문으로 이동합니다.

Risk (−)

내부자 공개시장 매도 클러스터↗

Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.

실적 서프라이즈 (퀀트 맥락)

최근 퀀트 스캔에 캐시된 Yahoo/공개 펀더멘털 수치입니다 — 공시 이벤트 점수에 합산되지 않으며 매수 신호가 아닙니다. 최신 발표보다 늦을 수 있습니다.

최근 보고 서프라이즈 +0.4%

Filings & events

Recent SEC disclosures and earnings dates — context only, not a trade signal.

as of 2026-08-17·sec_edgar·CIK 0001093557
Next earnings
2026-10-29yahoo_calendar
Last earnings
—

SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.